215 related articles for article (PubMed ID: 7588946)
21. Evaluation of technetium 99m cyclobutylpropylene amine oxime as a potential brain perfusion imaging agent for SPET.
Bacciottini L; Lunghi F; Pupi A; Bonino C; Formiconi AR; De Cristofaro MT; Petti AR; Meldolesi U
Eur J Nucl Med; 1990; 17(5):242-7. PubMed ID: 2083559
[TBL] [Abstract][Full Text] [Related]
22. [Cerebral perfusion reserve SPECT imaging before and during acetazolamide test using consecutive 99mTc-HMPAO SPECT].
Terada H; Gomi T; Furukawa T; Murakami S; Sato S; Nagamoto M; Sekiguchi R; Kuwajima A; Hiramatsu Y; Sakai T
Kaku Igaku; 1991 May; 28(5):509-15. PubMed ID: 1886285
[No Abstract] [Full Text] [Related]
23. Functional neuroimaging strategy in temporal lobe epilepsy: a comparative study of 18FDG-PET and 99mTc-HMPAO-SPECT.
Ryvlin P; Philippon B; Cinotti L; Froment JC; Le Bars D; Mauguière F
Ann Neurol; 1992 Jun; 31(6):650-6. PubMed ID: 1514777
[TBL] [Abstract][Full Text] [Related]
24. SPECT evaluation of brain perfusion reserve by the acetazolamide test using Tc-99m HMPAO.
Matsuda H; Higashi S; Kinuya K; Tsuji S; Nozaki J; Sumiya H; Hisada K; Yamashita J
Clin Nucl Med; 1991 Aug; 16(8):572-9. PubMed ID: 1934810
[TBL] [Abstract][Full Text] [Related]
25. Use of technetium-99m hexamethylpropylene amine oxime SPET for the study of cerebral blood flow reactivity after acetazolamide infusion in patients with Behçet's disease.
Pupi A; Sestini S; De Cristofaro MT; Emmi L; Marchione T; Salvati G; Gobbi FL; Massacesi L; Meldolesi U
Eur J Nucl Med; 2000 Jun; 27(6):700-6. PubMed ID: 10901457
[TBL] [Abstract][Full Text] [Related]
26. Different uptake of 99mTc-ECD adn 99mTc-HMPAO in the same brains: analysis by statistical parametric mapping.
Hyun Y; Lee JS; Rha JH; Lee IK; Ha CK; Lee DS
Eur J Nucl Med; 2001 Feb; 28(2):191-7. PubMed ID: 11303889
[TBL] [Abstract][Full Text] [Related]
27. Technetium-99m HMPAO SPET in acute supratentorial ischaemic infarction, expressing deficits as millilitre of zero perfusion.
Dierckx RA; Dobbeleir A; Pickut BA; Timmermans L; Dierckx I; Vervaet A; Vandevivere J; Deberdt W; De Deyn PP
Eur J Nucl Med; 1995 May; 22(5):427-33. PubMed ID: 7641751
[TBL] [Abstract][Full Text] [Related]
28. Benzodiazepine receptors and cerebral blood flow in partial epilepsy.
Bartenstein P; Ludolph A; Schober O; Lottes G; Scheidhauer K; Sciuk J; Beer HF
Eur J Nucl Med; 1991; 18(2):111-8. PubMed ID: 1646108
[TBL] [Abstract][Full Text] [Related]
29. [Comparison of cerebral vasoreactivity to acetazolamide in normal volunteer among 123I-IMP, 99mTc-ECD and 99mTc-HMPAO].
Makino K; Masuda Y; Gotoh S
Kaku Igaku; 1996 May; 33(5):551-5. PubMed ID: 8699624
[TBL] [Abstract][Full Text] [Related]
30. Tumour-like thallium-201 accumulation in brain infarcts, an unexpected finding on single-photon emission tomography.
Bernat I; Toth G; Kovács L
Eur J Nucl Med; 1994 Mar; 21(3):191-5. PubMed ID: 8200385
[TBL] [Abstract][Full Text] [Related]
31. Brain imaging of an alcoholic with MRI, SPECT, and PET.
Wang GJ; Volkow ND; Hitzemann R; Oster ZH; Roque C; Cestaro V
Am J Physiol Imaging; 1992; 7(3-4):194-8. PubMed ID: 1343215
[TBL] [Abstract][Full Text] [Related]
32. Functional neuroimaging in Alzheimer's disease: how far should we go?
Kerwin R
Eur J Nucl Med; 1994 Oct; 21(10):1041-3. PubMed ID: 7828612
[No Abstract] [Full Text] [Related]
33. Does technetium-99m bicisate image local brain metabolism in late ictal temporal lobe epilepsy?
Kuikka JT; Mervaala E; Vanninen E; Kälviäinen R
Eur J Nucl Med; 1994 Nov; 21(11):1247-51. PubMed ID: 7859780
[TBL] [Abstract][Full Text] [Related]
34. Parameters influencing SPET regional brain uptake of technetium-99m hexamethylpropylene amine oxine measured by calibrated point sources as an external standard.
Dierckx RA; Dobbeleir A; Maes M; Pickut BA; Vervaet A; De Deyn PP
Eur J Nucl Med; 1994 Jun; 21(6):514-20. PubMed ID: 8082666
[TBL] [Abstract][Full Text] [Related]
35. [Linealization correction for acetazolamide (Diamox) 99mTc-HMPAO SPECT image--a comparative study with PET].
Kuwabara Y; Ichiya Y; Sasaki M; Akashi Y; Yoshida T; Fukumura T; Masuda K
Kaku Igaku; 1994 Mar; 31(3):277-82. PubMed ID: 8176867
[TBL] [Abstract][Full Text] [Related]
36. Technetium-99m hexamethylpropylene amine oxime single photon emission tomography in febrile convulsions.
Dierckx RA; Melis K; Dom L; Janssens G; Luysterborgh E; De Deyn PP; Vandevivere J
Eur J Nucl Med; 1992; 19(4):278-82. PubMed ID: 1597244
[TBL] [Abstract][Full Text] [Related]
37. 99mTc-HMPAO-SPECT with acetazolamide challenge to detect hemodynamic compromise in occlusive cerebrovascular disease.
Knop J; Thie A; Fuchs C; Siepmann G; Zeumer H
Stroke; 1992 Dec; 23(12):1733-42. PubMed ID: 1448823
[TBL] [Abstract][Full Text] [Related]
38. Watershed ischemia demonstrated with acetazolamide enhanced Tc-99m HMPAO SPECT.
Bohdiewicz P; Juni JE
Clin Nucl Med; 1994 May; 19(5):452-4. PubMed ID: 7748255
[TBL] [Abstract][Full Text] [Related]
39. Changes in local cerebral blood flow by neuroactivation and vasoactivation in patients with impaired cognitive function.
Knapp WH; Dannenberg C; Marschall B; Zedlick D; Löschmann K; Bettin S; Barthel H; Seese A
Eur J Nucl Med; 1996 Aug; 23(8):878-88. PubMed ID: 8753675
[TBL] [Abstract][Full Text] [Related]
40. Brain Perfusion Imaging Under Acetazolamide Challenge for Detection of Impaired Cerebrovascular Reserve Capacity: Positive Findings with
Acker G; Lange C; Schatka I; Pfeifer A; Czabanka MA; Vajkoczy P; Buchert R
J Nucl Med; 2018 Feb; 59(2):294-298. PubMed ID: 28729429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
